{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T02:48:27Z","timestamp":1793760507479,"version":"4.6.1"},"reference-count":66,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,5]],"date-time":"2026-07-05T00:00:00Z","timestamp":1783209600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008982","name":"Qatar Research Development and Innovation Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.biopha.2026.119748","type":"journal-article","created":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T11:17:08Z","timestamp":1783941428000},"page":"119748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Iron biomarkers for prognosis, diagnosis, and therapeutic insight in colorectal cancer"],"prefix":"10.1016","volume":"201","author":[{"given":"Amani","family":"Benamor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4312-5076","authenticated-orcid":false,"given":"Peter","family":"Kubatka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5196-3366","authenticated-orcid":false,"given":"Dietrich","family":"B\u00fcsselberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2026.119748_bib1","doi-asserted-by":"crossref","unstructured":"Morgan E., Arnold M., Gini A., Lorenzoni V., Cabasag C.J., Laversanne M., et al. Global burden of colorectal cancer in 2020 and 2040: incidence and mortality estimates from GLOBOCAN [Internet]. 2023 Feb 1. doi:10.1136\/gutjnl-2022-327736.","DOI":"10.1136\/gutjnl-2022-327736"},{"key":"10.1016\/j.biopha.2026.119748_bib2","article-title":"The prognostic role of circulating CA19\u20139 and CEA in patients with colorectal cancer","volume":"43","author":"Gramkow","year":"2025","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119748_bib3","article-title":"Methylated Septin9 identified patients with colorectal carcinoma and showed higher sensitivity than conventional biomarkers in detecting tumor","volume":"36","author":"Leerhoff","year":"2023","journal-title":"Cancer Treat. Res. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119748_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgast-2019-000355","article-title":"Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy","volume":"7","author":"Hariharan","year":"2020","journal-title":"BMJ Open. Gastroenterol."},{"key":"10.1016\/j.biopha.2026.119748_bib5","doi-asserted-by":"crossref","unstructured":"Litvak A., Cercek A., Segal N., Reidy-Lagunes D., Stadler Z.K., Yaeger R.D., et al. False-Positive Elevations of Carcinoembryonic Antigen in Patients With a History of Resected Colorectal Cancer [Internet]. 2014 Jun 1. doi:10.6004\/jnccn.2014.0085.","DOI":"10.6004\/jnccn.2014.0085"},{"issue":"1","key":"10.1016\/j.biopha.2026.119748_bib6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12876-020-01377-x","article-title":"Expression of tumor pyruvate kinase M2 isoform in plasma and stool of patients with colorectal cancer or adenomatous polyps","volume":"20","author":"Rigi","year":"2020","journal-title":"BMC Gastroenterol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119748_bib7","doi-asserted-by":"crossref","first-page":"926","DOI":"10.3390\/bios13100926","article-title":"Current Status and Emerging Trends in Colorectal Cancer Screening and Diagnostics","volume":"13","author":"Beniwal","year":"2023","journal-title":"Biosens. (Basel)"},{"issue":"3","key":"10.1016\/j.biopha.2026.119748_bib8","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.31557\/APJCP.2023.24.3.1027","article-title":"The Clinical Significance of Septin 9 and Colon Cancer Specific Antigen-2 (CCSA-2) in Colorectal Cancer","volume":"24","author":"Abd El Kader","year":"2023","journal-title":"Asian Pac. J. Cancer Prev."},{"key":"10.1016\/j.biopha.2026.119748_bib9","unstructured":"Ladabaum U., Allen J., Wandell M., Ramsey S. COLORECTAL CANCER SCREENING WITH BLOOD-BASED BIOMARKERS: COST-EFFECTIVENESS OF METHYLATED SEPTIN 9 DNA VS. CURRENT STRATEGIES."},{"issue":"1","key":"10.1016\/j.biopha.2026.119748_bib10","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1186\/s12876-020-01377-x","article-title":"Expression of tumor pyruvate kinase M2 isoform in plasma and stool of patients with colorectal cancer or adenomatous polyps","volume":"20","author":"Rigi","year":"2020","journal-title":"BMC Gastroenterol."},{"key":"10.1016\/j.biopha.2026.119748_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.778492","article-title":"The Role of Iron in Cancer Progression","volume":"11","author":"Guo","year":"2021","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119748_bib12","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal. Transduct. Target. Ther."},{"issue":"11","key":"10.1016\/j.biopha.2026.119748_bib13","doi-asserted-by":"crossref","first-page":"5163","DOI":"10.3390\/ijms26115163","article-title":"Sex Hormones and Iron-Related Biomarkers Associate with EMT Features and Tumor Stage in Colorectal Cancer: A Serum- and Tissue-Based Analysis","volume":"26","author":"Squitti","year":"2025","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2026.119748_bib14","article-title":"Limitations of Serum Ferritin in Diagnosing Iron Deficiency in Inflammatory Conditions","volume":"2018","author":"Dignass","year":"2018","journal-title":"Int. J. Chronic Dis."},{"issue":"2","key":"10.1016\/j.biopha.2026.119748_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.semnephrol.2016.02.001","article-title":"Iron Balance and the Role of Hepcidin in Chronic Kidney Disease","volume":"36","author":"Ganz","year":"2016","journal-title":"Semin. Nephrol."},{"issue":"10","key":"10.1016\/j.biopha.2026.119748_bib16","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.3390\/genes16101166","article-title":"Crossroads of Iron Metabolism and Inflammation in Colorectal Carcinogenesis: Molecular Mechanisms and Therapeutic Perspectives","volume":"16","author":"Ahmadi","year":"2025","journal-title":"Genes"},{"issue":"6","key":"10.1016\/j.biopha.2026.119748_bib17","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1007\/s13402-023-00828-3","article-title":"Iron metabolism in colorectal cancer: a balancing act","volume":"46","author":"Est\u00eav\u00e3o","year":"2023","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"10.1016\/j.biopha.2026.119748_bib18","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s00018-025-05812-8","article-title":"Ferroptosis in cancer: revealing the multifaceted functions of mitochondria","volume":"82","author":"Ding","year":"2025","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"10.1016\/j.biopha.2026.119748_bib19","unstructured":"Suhail ali. Serum biomarkers of inflammation (ferritin, IL-8, TNFR1) and outcomes in BOLERO-2, a phase III trial of HR+\/HER2- metastatic breast cancer treated with everolimus (mTOR inhibitor). | Request PDF [Internet]. Available from: \u3008https:\/\/www.researchgate.net\/publication\/341630885_Serum_biomarkers_of_inflammation_ferritin_IL-8_TNFR1_and_outcomes_in_BOLERO-2_a_phase_III_trial_of_HRHER2-_metastatic_breast_cancer_treated_with_everolimus_mTOR_inhibitor\u3009."},{"issue":"1","key":"10.1016\/j.biopha.2026.119748_bib20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1186\/s12964-024-01769-6","article-title":"Inhibition of IRP2-dependent reprogramming of iron metabolism suppresses tumor growth in colorectal cancer","volume":"22","author":"Hwang","year":"2024","journal-title":"Cell. Commun. Signal."},{"issue":"8","key":"10.1016\/j.biopha.2026.119748_bib21","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1080\/15548627.2016.1187366","article-title":"Autophagy promotes ferroptosis by degradation of ferritin","volume":"12","author":"Hou","year":"2016","journal-title":"Autophagy"},{"key":"10.1016\/j.biopha.2026.119748_bib22","series-title":"Iron Physiology and Pathophysiology in Humans [Internet]","first-page":"357","article-title":"Hepatic Pathobiology of Iron Overload","author":"Ruddell","year":"2012"},{"key":"10.1016\/j.biopha.2026.119748_bib23","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.freeradbiomed.2025.05.393","article-title":"Lipid peroxidation, ferroptosis, and antioxidants","volume":"237","author":"Noguchi","year":"2025","journal-title":"Free. Radic. Biol. Med."},{"issue":"7","key":"10.1016\/j.biopha.2026.119748_bib24","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.devcel.2025.02.004","article-title":"Mechanisms of ferroptosis sensitization and resistance","volume":"60","author":"Lee","year":"2025","journal-title":"Dev. Cell."},{"key":"10.1016\/j.biopha.2026.119748_bib25","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/bs.vh.2019.01.002","article-title":"Hepcidin-ferroportin axis in health and disease","volume":"110","author":"Ginzburg","year":"2019","journal-title":"Vitam. Horm."},{"key":"10.1016\/j.biopha.2026.119748_bib26","doi-asserted-by":"crossref","unstructured":"Post-Transcriptional Regulation of Iron Homeostasis in Saccharomyces cerevisiae [Internet]. [cited 2026 May 30]. Available from: \u3008https:\/\/www.mdpi.com\/1422-0067\/14\/8\/15785\u3009.","DOI":"10.3390\/ijms140815785"},{"key":"10.1016\/j.biopha.2026.119748_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jprot.2021.104246","article-title":"Proteomics study of colorectal cancer and adenomatous polyps identifies TFR1, SAHH, and HV307 as potential biomarkers for screening","volume":"243","author":"Tang","year":"2021","journal-title":"J. Proteom."},{"key":"10.1016\/j.biopha.2026.119748_bib28","article-title":"Targeting ferroptosis regulators by natural products in colorectal cancer","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119748_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2020.109021","article-title":"Iron and hepcidin mediate human colorectal cancer cell growth","volume":"319","author":"Sornjai","year":"2020","journal-title":"Chem. Biol. Interact."},{"issue":"5","key":"10.1016\/j.biopha.2026.119748_bib30","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1007\/s11010-024-05148-0","article-title":"Cytoglobin augments ferroptosis through autophagic degradation of ferritin in colorectal cancer cells","volume":"480","author":"Fan","year":"2025","journal-title":"Mol. Cell. Biochem."},{"issue":"2","key":"10.1016\/j.biopha.2026.119748_bib31","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1080\/21655979.2021.2017627","article-title":"Prognostic and therapeutic significance of a novel ferroptosis related signature in colorectal cancer patients","volume":"13","author":"Du","year":"2022","journal-title":"Bioengineered"},{"issue":"1","key":"10.1016\/j.biopha.2026.119748_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11010-024-04956-8","article-title":"Abnormal upregulation of NUBP2 contributes to cancer progression in colorectal cancer","volume":"480","author":"Lan","year":"2025","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.biopha.2026.119748_bib33","unstructured":"Duan L., Cao L., Liu J., Wang Z., Liang J., Feng F. Identification of Ferroptosis-Related Prognostic Models and FDFT1."},{"issue":"7","key":"10.1016\/j.biopha.2026.119748_bib34","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1038\/s42255-021-00406-7","article-title":"Hepcidin sequesters iron to sustain nucleotide metabolism and mitochondrial function in colorectal cancer epithelial cells","volume":"3","author":"Schwartz","year":"2021","journal-title":"Nat. Metab."},{"key":"10.1016\/j.biopha.2026.119748_bib35","article-title":"Distinctive modulation of hepcidin in cancer and its therapeutic relevance","volume":"13","author":"Lin","year":"2023","journal-title":"Front. Oncol."},{"issue":"12","key":"10.1016\/j.biopha.2026.119748_bib36","first-page":"22293","article-title":"The association between serum ferritin with colorectal cancer","volume":"8","author":"Feng","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.biopha.2026.119748_bib37","unstructured":"Evaluation of Serum CEA, CA19-9, CA72-4, CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports [Internet]. [cited 2026 May 30]. Available from: \u3008https:\/\/www.nature.com\/articles\/s41598-018-21048-y\u3009."},{"key":"10.1016\/j.biopha.2026.119748_bib38","unstructured":"Cao L.L., Liu H.Q., Yue Z.H., Pei L., Wang H., Jia M. Ferritin is a potential tumor marker for colorectal cancer and modulates histone methylation in colorectal cancer cells."},{"issue":"8","key":"10.1016\/j.biopha.2026.119748_bib39","doi-asserted-by":"crossref","first-page":"957","DOI":"10.7150\/jca.14797","article-title":"Serum Ferritin as a Prognostic Biomarker for Survival in Relapsed or Refractory Metastatic Colorectal Cancer","volume":"7","author":"Lee","year":"2016","journal-title":"J. Cancer"},{"issue":"23","key":"10.1016\/j.biopha.2026.119748_bib40","doi-asserted-by":"crossref","first-page":"3977","DOI":"10.3390\/cancers16233977","article-title":"Circulating Hepcidin Levels Are an Independent Predictor of Survival in Microsatellite Stable Metastatic Colorectal Cancer Patient Candidates for Standard First-Line Treatment","volume":"16","author":"Formica","year":"2024","journal-title":"Cancers"},{"issue":"7","key":"10.1016\/j.biopha.2026.119748_bib41","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1038\/s41416-024-02814-4","article-title":"Prognostic value of post-operative iron biomarkers in colorectal cancer: population-based patient cohort","volume":"131","author":"Gwenzi","year":"2024","journal-title":"Br. J. Cancer"},{"issue":"9","key":"10.1016\/j.biopha.2026.119748_bib42","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3748\/wjg.14.1339","article-title":"Increased hepcidin expression in colorectal carcinogenesis","volume":"14","author":"Ward","year":"2008","journal-title":"World J. Gastroenterol."},{"issue":"1","key":"10.1016\/j.biopha.2026.119748_bib43","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/s40164-024-00562-y","article-title":"Targeting hepcidin in colorectal cancer triggers a TNF-dependent-gasdermin E-driven immunogenic cell death response","volume":"13","year":"2024","journal-title":"Exp. Hematol. Oncol."},{"key":"10.1016\/j.biopha.2026.119748_bib44","doi-asserted-by":"crossref","unstructured":"Szymulewska-Konopko K., Resze\u0107-Gie\u0142a\u017cyn J., Ma\u0142eczek M., Szymulewska-Konopko K., Resze\u0107-Gie\u0142a\u017cyn J., Ma\u0142eczek M. Ferritin as an Effective Prognostic Factor and Potential Cancer Biomarker [Internet]. 2025. Available from: \u3008https:\/\/www.mdpi.com\/1467-3045\/47\/1\/60\u3009.","DOI":"10.3390\/cimb47010060"},{"key":"10.1016\/j.biopha.2026.119748_bib45","unstructured":"Serum CEA E, CA19\u20139\u2009C 4. CA125 and Ferritin as Diagnostic Markers and Factors of Clinical Parameters for Colorectal Cancer | Scientific Reports [Internet [Internet]. Available from: \u3008https:\/\/www.nature.com\/articles\/s41598-018-21048-y\u3009."},{"key":"10.1016\/j.biopha.2026.119748_bib46","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.3389\/fphar.2018.01371","article-title":"RSL3 Drives Ferroptosis Through GPX4 Inactivation and ROS Production in Colorectal Cancer","volume":"9","author":"Sui","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.biopha.2026.119748_bib47","doi-asserted-by":"crossref","unstructured":"Leli\u00e8vre P. Iron Dysregulation in Human Cancer: Altered Metabolism, Biomarkers for Diagnosis, Prognosis, Monitoring and Rationale for Therapy [Internet [Internet]. Available from: \u3008https:\/\/www.mdpi.com\/2072-6694\/12\/12\/3524\u3009.","DOI":"10.3390\/cancers12123524"},{"key":"10.1016\/j.biopha.2026.119748_bib48","unstructured":"Zhe F. The association between serum ferritin with colorectal cancer [Internet]. Available from: \u3008https:\/\/pmc.ncbi.nlm.nih.gov\/articles\/PMC4729992\/\u3009."},{"issue":"1","key":"10.1016\/j.biopha.2026.119748_bib49","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF01229068","article-title":"Clinical significance of serum iron and ferritin in patients with colorectal cancer","volume":"29","author":"Kishida","year":"1994","journal-title":"J. Gastroenterol."},{"issue":"11","key":"10.1016\/j.biopha.2026.119748_bib50","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1002\/cbin.12072","article-title":"Gambogenic acid inhibits proliferation and ferroptosis by targeting the miR-1291\/FOXA2 and AMPK\u03b1\/SLC7A11\/GPX4 axis in colorectal cancer","volume":"47","author":"Ma","year":"2023","journal-title":"Cell. Biol. Int."},{"issue":"17","key":"10.1016\/j.biopha.2026.119748_bib51","doi-asserted-by":"crossref","first-page":"35","DOI":"10.4103\/0973-7847.156333","article-title":"Hepcidin SRSK. A novel biomarker with changing trends","volume":"9","author":"Kali","year":"2015","journal-title":"Pharmacogn. Rev."},{"key":"10.1016\/j.biopha.2026.119748_bib52","unstructured":"Xia W., Lv Y., Zou Y., Kang Z., Li Z., Tian J. The role of ferroptosis in colorectal cancer and its potential synergy with immunotherapy [Internet]. Available from: \u3008https:\/\/www.frontiersin.org\/journals\/immunology\/articles\/10.3389\/fimmu.2024.1526749\/full\u3009."},{"issue":"9","key":"10.1016\/j.biopha.2026.119748_bib53","doi-asserted-by":"crossref","first-page":"3189","DOI":"10.3390\/jcm14093189","article-title":"Carcinoembryonic Antigen (CEA): Origin, Role in Oncology, and Concentrations in Serum and Peritoneal Fluid","volume":"14","author":"Niedzielska","year":"2025","journal-title":"J. Clin. Med."},{"key":"10.1016\/j.biopha.2026.119748_bib54","unstructured":"Kankanala V.L., Zubair M., Mukkamalla S.K.R. Carcinoembryonic Antigen [Internet]. Available from: \u3008http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK578172\/\u3009."},{"issue":"23","key":"10.1016\/j.biopha.2026.119748_bib55","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.3390\/cancers16234068","article-title":"Hepcidin Is a Valuable Therapeutic Target for Colorectal Cancer","volume":"16","author":"Frascatani","year":"2024","journal-title":"Cancers"},{"issue":"21","key":"10.1016\/j.biopha.2026.119748_bib56","doi-asserted-by":"crossref","first-page":"5294","DOI":"10.3390\/cancers14215294","article-title":"Hepcidin Upregulation in Colorectal Cancer Associates with Accumulation of Regulatory Macrophages and Epithelial-Mesenchymal Transition and Correlates with Progression of the Disease","volume":"14","author":"A G","year":"2022","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.biopha.2026.119748_bib57","doi-asserted-by":"crossref","first-page":"7042","DOI":"10.1038\/s41467-025-62218-7","article-title":"Biomarker panels for improved risk prediction and enhanced biological insights in patients with atrial fibrillation","volume":"16","author":"Meyre","year":"2025","journal-title":"Nat. Commun."},{"issue":"1","key":"10.1016\/j.biopha.2026.119748_bib58","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s40001-022-00922-6","article-title":"How to diagnose iron deficiency in chronic disease: A review of current methods and potential marker for the outcome","volume":"28","author":"Rohr","year":"2023","journal-title":"Eur. J. Med. Res."},{"issue":"6","key":"10.1016\/j.biopha.2026.119748_bib59","doi-asserted-by":"crossref","first-page":"284","DOI":"10.3892\/ol.2024.14417","article-title":"Exploring the prognostic significance of iron death-related lncRNAs in colorectal cancer: A systematic review and meta-analysis","volume":"27","author":"Hang","year":"2024","journal-title":"Oncol. Lett."},{"issue":"3","key":"10.1016\/j.biopha.2026.119748_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.267","article-title":"The epigenetic regulatory mechanisms of ferroptosis and its implications for biological processes and diseases","volume":"4","author":"Yang","year":"2023","journal-title":"MedComm"},{"key":"10.1016\/j.biopha.2026.119748_bib61","article-title":"Methylated Septin9 identified patients with colorectal carcinoma and showed higher sensitivity than conventional biomarkers in detecting tumor","volume":"36","author":"Leerhoff","year":"2023","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119748_bib62","article-title":"The prognostic role of circulating CA19\u20139 and CEA in patients with colorectal cancer","volume":"43","author":"Gramkow","year":"2025","journal-title":"Cancer Treat. Res. Commun."},{"key":"10.1016\/j.biopha.2026.119748_bib63","unstructured":"BioChain (Beijing) Science and Technology, Inc. Screening of Colorectal Cancer Using Improved SEPT9 (Septin 9) Gene Methylation Assay in Chinese Population [Clinical trial registration] [Internet]. clinicaltrials.gov; 2016 Jan [cited 2026 Jun 24]. Clinical trial registration no.: NCT02540850. Available from: \u3008https:\/\/clinicaltrials.gov\/study\/NCT02540850\u3009."},{"key":"10.1016\/j.biopha.2026.119748_bib64","unstructured":"City of Hope Medical Center. A Liquid Biopsy Assay For The Non-Invasive Early Detection of Advanced Adenomas and Colorectal Cancer [Clinical trial registration] [Internet]. clinicaltrials.gov; 2026 Jun [cited 2026 Jun 24]. Clinical trial registration no.: NCT06342440. Available from: \u3008https:\/\/clinicaltrials.gov\/study\/NCT06342440\u3009."},{"key":"10.1016\/j.biopha.2026.119748_bib65","unstructured":"Epigenomics, Inc. Clinical Sample Protocol for Plasma-based Colorectal Cancer Screening Research & Development [Clinical trial registration] [Internet]. clinicaltrials.gov; 2021 Feb [cited 2026 Jun 24]. Clinical trial registration no.: NCT04027790. Available from: \u3008https:\/\/clinicaltrials.gov\/study\/NCT04027790\u3009."},{"issue":"12","key":"10.1016\/j.biopha.2026.119748_bib66","article-title":"Blood CEA levels for detecting recurrent colorectal cancer","volume":"2015","author":"Nicholson","year":"2015","journal-title":"Cochrane Database Syst. Rev."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007845?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332226007845?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T06:34:28Z","timestamp":1784529268000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332226007845"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":66,"alternative-id":["S0753332226007845"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119748","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iron biomarkers for prognosis, diagnosis, and therapeutic insight in colorectal cancer","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2026.119748","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"119748"}}